JACCMcdermott et al.cohort
Greater 2-year walking distance decline in PAD is linked to ~3.5-fold higher risk of mobility loss.
Serial annual office-based functional performance testing over two years identifies PAD patients at significantly elevated risk for subsequent mobility loss, all-cause mortality, and cardiovascular mortality independently of baseline functional status and ABI.

